Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
40.53
-0.84 (-2.03%)
At close: Mar 20, 2026, 4:00 PM EDT
41.62
+1.09 (2.69%)
After-hours: Mar 20, 2026, 7:54 PM EDT
Vera Therapeutics Market Cap
Vera Therapeutics has a market cap or net worth of $2.89 billion as of March 20, 2026. Its market cap has increased by 54.83% in one year.
Market Cap
2.89B
Enterprise Value
2.25B
1-Year Change
54.83%
Ranking
Category
Stock Price
$40.53
Market Cap Chart
Since the IPO on May 14, 2021, Vera Therapeutics's market cap has increased from $225.27M to $2.89B, an increase of 1,183.80%. That is a compound annual growth rate of 69.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 2.89B | -19.55% |
| Dec 31, 2025 | 3.59B | 34.24% |
| Dec 31, 2024 | 2.68B | 291.87% |
| Dec 29, 2023 | 683.38M | 27.69% |
| Dec 30, 2022 | 535.18M | -5.87% |
| Dec 31, 2021 | 568.54M | 152.38% |
| May 14, 2021 | 225.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edgewise Therapeutics | 3.17B |
| Alumis | 3.12B |
| Telix Pharmaceuticals | 2.98B |
| Dyne Therapeutics | 2.95B |
| IDEAYA Biosciences | 2.88B |
| Arcutis Biotherapeutics | 2.86B |
| Tarsus Pharmaceuticals | 2.81B |
| Viridian Therapeutics | 2.80B |